[1] ZHAO D,LIU J,WANG M,et al.Epidemiology of cardiovascular disease in China:Current features and implications[J].Nat Rev Cardiol,2019,16(4):203-212. [2] World Health Organization.WHO| Cardiovascular diseases(CVDs) factsheet[EB/OL].(2021-06-11)[2025-01-22].https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). [3] WELTY F K.How do elevated Triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis?[J].Curr Cardiol Re,2013, 15(9):400. [4] HABIB S S,AL-KHLAIWI T,BUTT M A,et al.Novel adiponectin-re sistin indices and ratios predict increased cardiovascular risk in patients with type 2 diabetes mellitus[J].J Saudi Heart Assoc,2023,35(1):59-65. [5] AL-KHLAIWI T,HABIB S S,Al-KHLIWI H,et al.Relationship of serum inducible and endothelial nitric oxide synthase with exercise in healthy adult males and patients with type 2 diabetes mellitus[J].Eur Rev Med Pharmacol Sci,2023,27(10):4619-4625. [6] HABIB S S,AL-KHLAIWI T,HABIB S M,et al.Predictive value of arm circumference(AC) and arm muscle circumference(AMC) with cardiovascular risk in healthy and diabetic males[J].Eur Rev Med Pharmacol Sci,2023,27(6):2477-2484. [7] BASZCZUK A,KOPCZYNSKI Z.Hyperhomocysteinemia in patients with cardiovascular disease[J].Postepy Hig Med Dosw(Online),2014,68:579-589. [8] HABIB S S,AL-KHLAIWI T,ALMUSHAWAH A,et al.Homocysteine as a predictor and prognostic marker of atherosclerotic cardiovascular disease:A systematic review and meta-analysis[J].Eur Rev Med Pharmacol Sci,2023,27(18):8598-8608. [9] BOUSHEY C J,BERESFORD S A,OMENN G S,et al.A quantitative assessment of plasma homocysteine as a risk factor for vascular disease.Probable benefits of increasing folic acid intakes[J].JAMA,1995, 274(13):1049-1057. [10] PAN L,YANG Z,WU Y,et al.The prevalence,awareness,treatment and control of dyslipidemia among adultsin China[J].Atherosclerosis,2016,248(5):2-9. [11] NIU X,CHEN J,WANG J,et al.A cross-sectional study on the relationship between homocysteine and lipid profiles among Chinese population from Hunan[J].Lipids,2021,56(1):93-100. [12 ]QIN Y Y,WANG P,QIN J Q,et al.Prevalence of hyperhomocysteinemia during routine physical examination in Guangxi Province,China and related risk factors[J].J Clin Lab Anal,2018,32(1):e22178. [13] BAO F,CUI M,SHI X,et al.Distribution characteristics and influencing factors of homocyteine in an apparently healthy examined population[J].BMC Cardiovasc Disord,2021,21(1):429. [14] ASZTALOS B F,HORVATH K V,SCHAEFER E J.High-density lipoprotein particles,cell-cholesterol efflux,and coronary heart disease risk[J].Arterioscler Thromb Vasc Biol,2018,38(9):2007-2015. [15] DIDICHENKO S A,NAVDAEV A V,CUKIER A M,et al.Enhanced HDL functionality in small HDL species produced upon remodeling of HDL by reconstituted HDL,CSL112:Effects on cholesterol efflux anti-inflammatory and antioxidative activity[J].Circ Res,2016,119(6):751-763. [16] ANTONIADES C,ANTONOPOULOS A S,TOUSOULIS D,et al.Homocysteine and coronary atherosclerosis:From folate fortification to the recent clinical trials[J].Eur Heart J,2009,30(1):6-15. [17] SHENOV V,MEHENDALE V,PRABHU K,et al.Correlation of serum homocysteine levels with the severity of coronary artery disease[J].Ind J Clin Biochem,2014,29(3):339-344. [18] 国家卫生计生委疾病预防控制局.中国居民营养与慢性病状况报告[M].北京:人民卫生出版社,2016:55-56. [19] FAEH D,CHIOLERO A,PACCAUD F.Homocysteine as a risk factor for cardiovascular disease:Should we(still) worry about it?[J] Swiss Med Wkly,2006,136(47-48):745-756. [20] MIKAEL L G,GENEST J R,ROZEN R.Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease[J].Circ Res,2006,98(4):564-571. [21] LIAO D,TAN H,HUI R,et al.Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance[J].Circ Res,2006,99(6):598-606. [22] WU D F,LIAO Q C,LU F,et al.Differential effects of hyperhomocysteinemia on the lipid profiles and lipid ratios between patients with and without coronary artery disease:A retrospective observational study[J].Medicine,2022,101(52):e32464. [23] LIAO D,YANG X,WANG H.Hyperhomocysteinemia and high-density lipoprotein metabolism in cardiovascular disease[J].Clin Chem Lab Med, 2007,45(12):1652-1659. |